Pulse Biosciences Pickes Former Boston Scientific Exec as New CEO

MassDeviceJan 10 22:25

Express News | Pulse Biosciences, Inc. Appoints Paul Laviolette as Chief Executive Officer

BreakingsJan 10 21:00

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

BusinesswireJan 10 21:00

Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.

In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.

Zhitong FinanceJan 6 10:18

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireJan 3 22:00

Pulse Biosciences,, On December 18, 2024, The Co's Co-Chairman And Majority Shareholder, Robert W. Duggan, Exercised All Of The Warrants He Acquired In The Co's 2024 Rights Offering, Corresponding To $58.4M Totaling To 5,306,156 Shares Of Company...

BenzingaDec 19, 2024 21:11